Melbourn, Cambridgeshire, United Kingdom
VP, Global Head of Companion Diagnostics and Head of Companion Diagnostics Unit Oncology at AstraZeneca
Pharmaceuticals
Education
University of California, San Diego - School of Medicine 2000 — 2002
Post-doc, Hematology/Oncology
Eberhard-Karls-Universität Tübingen 1992 — 1995
Diploma, Molecular Biology
Experience
AstraZeneca May 2014 - Present
Astrazeneca 2014 - 2015
F. Hoffmann-La Roche Ltd April 2009 - April 2014
F. Hoffmann-La Roche Ltd April 2002 - April 2009
Skills
Molecular Diagnostics, Pharmaceutical Industry, GCP, Translational Medicine, Pharmacokinetics, Cancer, Personalized Medicine, Medical Writing, Assay Development, IND, Drug Development, Medical Devices, CTMS, Immunology, Cell, Lifesciences, Inflammation, Clinical Trials, Biopharmaceuticals, Biomarkers, Hardware Diagnostics, Therapeutic Areas, Vaccines, Biologics, Regulatory Submissions, Virology, Molecular Biology, Clinical Research, In Vivo, Biotechnology, Infectious Diseases, Genomics, In Vitro, Pharmacodynamics, Biomarker Discovery, Medical Research, Hematology, FDA, Pharmacology, Translational Research, Oncology, Cell Biology, Neuroscience, Immunoassays, Drug Discovery, Diagnostics, Monoclonal Antibodies, Medical Affairs, CRO, Clinical Development